IMI2 – CALL 20
"TOPIC 3 : ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS (UNITE4TB)"
Publication date : 21 January 2020
Stage 1 submission deadline: Extended to 12 May 2020
Stage 2 submission deadline: Extended to 19 November 2020
Action type: Research and Innovation Action (RIA)
Update 08/04/2020: The deadline for submitting short proposals has been extended to 12 May 2020.
TOPICS :
The following topics are under consideration for inclusion in the next IMI Calls for proposals. These topics are now at an advanced stage of development and it is hoped that these drafts will allow potential applicants to start working actively on proposals and forming consortia.
Draft topic texts are subject to consultations involving IMI's States Representatives Group, Scientific Committee, and the European Commission. They must also be approved by the IMI Governing Board. Depending on the results of the consultations and approval process, the final topic text may differ significantly from the draft versions initially published, and applicants should always base their proposals on the final, approved topic texts which will be published when the Call is officially launched.
- Topic 1: Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis.
- Topic 2: Innovations to accelerate vaccine development and manufacture.
- Topic 3: Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
This topic is part of the IMI AMR Accelerator Programme. Applicants should also read the Questions and Answers on the programme (document last updated November 2019).
- Topic 4: Tumour plasticity
- Topic 5: Proton versus photon therapy for oesophageal cancer – a trimodality strategy
- Topic 6: Handling of protein drug products and stability concerns
FULL DETAILS OF THE TOPICS, INCLUDING THE BUDGET BREAKDOWN AND THE GENERAL CONDITIONS FOR THE CALL FOR PROPOSALS, ARE AVAILABLE ON THE IMI WEBSITE.
